Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Clinical trial NCT05421598 · COMPLETED
Trial details
- NCT number
- NCT05421598
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-10-11
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.